CN111903672A - Auxiliary agent for suspending agent and validamycin and carbendazim compound suspending agent - Google Patents
Auxiliary agent for suspending agent and validamycin and carbendazim compound suspending agent Download PDFInfo
- Publication number
- CN111903672A CN111903672A CN202010732832.8A CN202010732832A CN111903672A CN 111903672 A CN111903672 A CN 111903672A CN 202010732832 A CN202010732832 A CN 202010732832A CN 111903672 A CN111903672 A CN 111903672A
- Authority
- CN
- China
- Prior art keywords
- suspending agent
- validamycin
- agent
- carbendazim
- auxiliary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
- A01N47/18—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, directly attached to a heterocyclic or cycloaliphatic ring
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Toxicology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses an auxiliary agent for a suspending agent, which comprises the following raw materials: 15-65% of amphiphilic oil-based modified bisphenol A epoxy resin, 10-35% of triethanolamine dodecylbenzene sulfonate, 10-40% of phenethyl phenol polyoxyethylene ether and 10-45% of alkyl glycoside. The invention also discloses a validamycin and carbendazim compound suspending agent containing the auxiliary agent for the suspending agent, which comprises the following raw materials: 20% of carbendazim, 4% of validamycin, 8% of auxiliary agent for suspending agent, 0.3% of xanthan gum, 0.3% of benzoic acid, 0.5% of defoaming agent and 66.9% of water, and the auxiliary agent for suspending agent prepared by the method is added into the validamycin and carbendazim compound suspending agent, so that the phenomenon of bottom solidification during long-time storage of the validamycin and carbendazim compound suspending agent can be effectively prevented, and the phenomenon of layering is relieved.
Description
Technical Field
The invention relates to the technical field of pesticide manufacturing, and particularly relates to an auxiliary agent for a suspending agent and a validamycin and carbendazim compound suspending agent.
Background
Carbendazim is a broad-spectrum benzimidazole bactericide and is commonly used for sterilizing grains or fruits, validamycin is an antibiotic generated by actinomycetes, has strong systemic property, is easily absorbed by and quickly conducted in somatic cells, and interferes and inhibits the growth and development of the somatic cells, and the application method of the carbendazim and the validamycin is that the two are mixed and ground into particles and then uniformly dispersed in water to prepare a suspending agent.
Disclosure of Invention
The technical problem to be solved by the invention is as follows:
the validamycin and carbendazim compound suspending agent is easy to delaminate when being stored for a long time, and the problem of bottom solidification can occur.
In order to achieve the purpose, the invention adopts the following technical scheme:
an auxiliary agent for a suspending agent comprises the following raw materials: 15-65% of amphiphilic oil-based modified bisphenol A epoxy resin, 10-35% of triethanolamine dodecylbenzene sulfonate, 10-40% of phenethyl phenol polyoxyethylene ether and 10-45% of alkyl glycoside.
Further, the preparation method of the auxiliary agent for the suspending agent comprises the following steps:
and uniformly stirring the amphiphilic oil-based modified bisphenol A epoxy resin, triethanolamine dodecylbenzene sulfonate, phenethylphenol polyoxyethylene ether and alkyl glycoside to obtain the auxiliary agent for the suspending agent.
A validamycin and carbendazim compound suspending agent comprises any one of the above suspending agent auxiliary agent.
Further, the validamycin and carbendazim compound suspending agent comprises the following raw materials: 20% of carbendazim, 4% of validamycin, 8% of auxiliary agent for suspending agent, 0.3% of xanthan gum, 0.3% of benzoic acid, 0.5% of defoaming agent and 66.9% of water.
Further, the preparation method of the validamycin and carbendazim compound suspending agent comprises the following steps:
(1) adding the suspending agent and the auxiliary agent into water, and uniformly stirring to obtain an auxiliary agent solution;
(2) adding carbendazim and validamycin into the aid solution, and uniformly stirring to obtain a mixed solution;
(3) adding xanthan gum, benzoic acid and a defoaming agent into the mixed solution in sequence; and after being uniformly stirred, the mixture is sheared at a high speed and then is put into a grinding medium for grinding, and the validamycin and carbendazim compound suspending agent is obtained.
Further, the grinding time in the step (3) is 2-3 hours.
Further, the particle diameter D90 of the validamycin and carbendazim compound suspending agent is less than 5 microns.
The invention has the beneficial effects that:
the auxiliary agent for the suspending agent is prepared by uniformly stirring the amphiphilic oil-based modified bisphenol A epoxy resin, triethanolamine dodecylbenzene sulfonate, phenethylphenol polyoxyethylene ether and alkyl glycoside serving as raw materials, and is added into the validamycin and carbendazim compound suspending agent, so that the phenomenon of bottom solidification during long-time storage of the validamycin and carbendazim compound suspending agent can be effectively prevented, and the phenomenon of layering is relieved.
Detailed Description
An auxiliary agent for a suspending agent comprises the following raw materials:
15-65% of amphiphilic oil-based modified bisphenol A epoxy resin, 10-35% of triethanolamine dodecylbenzene sulfonate, 10-40% of phenethyl phenol polyoxyethylene ether and 10-45% of alkyl glycoside.
The preparation method of the auxiliary agent for the suspending agent comprises the following steps:
and uniformly stirring the amphiphilic oil-based modified bisphenol A epoxy resin, triethanolamine dodecylbenzene sulfonate, phenethylphenol polyoxyethylene ether and alkyl glycoside to obtain the auxiliary agent for the suspending agent.
A validamycin and carbendazim compound suspending agent comprises the following raw materials:
20% of carbendazim, 4% of validamycin, 8% of auxiliary agent for suspending agent, 0.3% of xanthan gum, 0.3% of benzoic acid, 0.5% of defoaming agent and 66.9% of water.
The preparation method of the validamycin and carbendazim compound suspending agent comprises the following steps:
(1) adding a suspending agent into water by using an aid, uniformly stirring to obtain an aid solution, (2) adding carbendazim and validamycin into the aid solution, uniformly stirring to obtain a mixed solution, (3) sequentially adding xanthan gum, benzoic acid and a defoaming agent into the mixed solution, uniformly stirring, then carrying out high-speed shearing, and then placing the mixed solution in a grinding medium for grinding for 2-3 hours to obtain the validamycin and carbendazim compound suspending agent with the particle size D90 smaller than 5 microns.
The auxiliary agent for the suspending agent can also be used for a monosultap and chlorfenapyr compound suspending agent and an oxyfluorfen and glyphosate compound suspending agent.
Example 1
An auxiliary agent for a suspending agent comprises the following raw materials:
50% of amphiphilic oil-based modified bisphenol A epoxy resin, 20% of triethanolamine dodecylbenzene sulfonate, 20% of phenethylphenol polyoxyethylene ether and 10% of alkyl glycoside.
The preparation method of the auxiliary agent for the suspending agent comprises the following steps:
and uniformly stirring the amphiphilic oil-based modified bisphenol A epoxy resin, triethanolamine dodecylbenzene sulfonate, phenethylphenol polyoxyethylene ether and alkyl glycoside to obtain the auxiliary agent for the suspending agent.
Example 2
An auxiliary agent for a suspending agent comprises the following raw materials:
15% of amphiphilic oil-based modified bisphenol A epoxy resin, 35% of triethanolamine dodecylbenzene sulfonate, 40% of phenethylphenol polyoxyethylene ether and 10% of alkyl glycoside.
The preparation method of the auxiliary agent for the suspending agent comprises the following steps:
and uniformly stirring the amphiphilic oil-based modified bisphenol A epoxy resin, triethanolamine dodecylbenzene sulfonate, phenethylphenol polyoxyethylene ether and alkyl glycoside to obtain the auxiliary agent for the suspending agent.
Example 3
An auxiliary agent for a suspending agent comprises the following raw materials:
40% of amphiphilic oil-based modified bisphenol A epoxy resin, 55% of triethanolamine dodecylbenzene sulfonate, 15% of phenethylphenol polyoxyethylene ether and 20% of alkyl glycoside.
The preparation method of the auxiliary agent for the suspending agent comprises the following steps:
and uniformly stirring the amphiphilic oil-based modified bisphenol A epoxy resin, triethanolamine dodecylbenzene sulfonate, phenethylphenol polyoxyethylene ether and alkyl glycoside to obtain the auxiliary agent for the suspending agent.
Example 4
An auxiliary agent for a suspending agent comprises the following raw materials:
25% of amphiphilic oil-based modified bisphenol A epoxy resin, 25% of triethanolamine dodecylbenzene sulfonate, 25% of phenethylphenol polyoxyethylene ether and 25% of alkyl glycoside.
The preparation method of the auxiliary agent for the suspending agent comprises the following steps:
and uniformly stirring the amphiphilic oil-based modified bisphenol A epoxy resin, triethanolamine dodecylbenzene sulfonate, phenethylphenol polyoxyethylene ether and alkyl glycoside to obtain the auxiliary agent for the suspending agent.
Example 5
A validamycin and carbendazim compound suspending agent comprises the following raw materials:
20% of carbendazim, 4% of validamycin, 8% of the auxiliary for the suspension prepared in example 1, 0.3% of xanthan gum, 0.3% of benzoic acid, 0.5% of an antifoaming agent, and 66.9% of water.
The preparation method of the validamycin and carbendazim compound suspending agent comprises the following steps:
(1) adding a suspending agent into water by using an aid, and uniformly stirring to obtain an aid solution, (2) adding carbendazim and validamycin into the aid solution, and uniformly stirring to obtain a mixed solution, (3) sequentially adding xanthan gum, benzoic acid and a defoaming agent into the mixed solution, uniformly stirring, then carrying out high-speed shearing, and then placing the mixed solution in a grinding medium for grinding for 2 hours to obtain the validamycin and carbendazim compound suspending agent with the particle size D90 smaller than 5 microns.
Example 6
A validamycin and carbendazim compound suspending agent comprises the following raw materials:
20% of carbendazim, 4% of validamycin, 8% of the auxiliary for the suspension prepared in example 2, 0.3% of xanthan gum, 0.3% of benzoic acid, 0.5% of an antifoaming agent, and 66.9% of water.
The preparation method of the validamycin and carbendazim compound suspending agent comprises the following steps:
(1) adding a suspending agent into water by using an aid, and uniformly stirring to obtain an aid solution, (2) adding carbendazim and validamycin into the aid solution, and uniformly stirring to obtain a mixed solution, (3) sequentially adding xanthan gum, benzoic acid and a defoaming agent into the mixed solution, uniformly stirring, then carrying out high-speed shearing, and then placing the mixed solution in a grinding medium for grinding for 2.4 hours to obtain the validamycin and carbendazim compound suspending agent with the particle size D90 smaller than 5 microns.
Example 7
A validamycin and carbendazim compound suspending agent comprises the following raw materials:
20% of carbendazim, 4% of validamycin, 8% of the auxiliary for the suspension prepared in example 3, 0.3% of xanthan gum, 0.3% of benzoic acid, 0.5% of an antifoaming agent, and 66.9% of water.
The preparation method of the validamycin and carbendazim compound suspending agent comprises the following steps:
(1) adding a suspending agent into water by using an aid, and uniformly stirring to obtain an aid solution, (2) adding carbendazim and validamycin into the aid solution, and uniformly stirring to obtain a mixed solution, (3) sequentially adding xanthan gum, benzoic acid and a defoaming agent into the mixed solution, uniformly stirring, then carrying out high-speed shearing, and then placing the mixed solution in a grinding medium for grinding for 2.8 hours to obtain the validamycin and carbendazim compound suspending agent with the particle size D90 of less than 5 microns.
Example 8
A validamycin and carbendazim compound suspending agent comprises the following raw materials:
20% of carbendazim, 4% of validamycin, 8% of the auxiliary for the suspension prepared in example 4, 0.3% of xanthan gum, 0.3% of benzoic acid, 0.5% of an antifoaming agent, and 66.9% of water.
The preparation method of the validamycin and carbendazim compound suspending agent comprises the following steps:
(1) adding a suspending agent into water by using an aid, and uniformly stirring to obtain an aid solution, (2) adding carbendazim and validamycin into the aid solution, uniformly stirring to obtain a mixed solution, (3) sequentially adding xanthan gum, benzoic acid and a defoaming agent into the mixed solution, uniformly stirring, then carrying out high-speed shearing, and then placing the mixed solution in a grinding medium for grinding for 3 hours to obtain the validamycin and carbendazim compound suspending agent with the particle size D90 smaller than 5 microns.
Experimental example:
the commercially available validamycin and carbendazim compound suspending agent product is taken as a comparative example, the validamycin and carbendazim compound suspending agent prepared in the examples 5-8 and the comparative example are respectively placed at 25 ℃ for two years and at 45 ℃ and 54 ℃ for fourteen days, and the experimental results are as follows:
table 1: delamination and consolidation phenomena for two years at 25 ℃ for examples and comparative examples
Table 2: delamination and consolidation phenomena for fourteen days at 45 ℃ for examples and comparative examples
Table 3: delamination and consolidation phenomena for fourteen days at 54 ℃ for examples and comparative examples
As can be seen from tables 1 to 3, in examples 5 to 8, compared with commercially available validamycin and carbendazim compound suspension products, the validamycin and carbendazim compound suspension prepared by using the auxiliary for a suspension of the present invention can effectively prevent the bottom solidification phenomenon during long-term storage and alleviate the delamination phenomenon, thereby effectively increasing the storage time of the validamycin and carbendazim compound suspension.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be able to cover the technical scope of the present invention by equivalent replacement or change according to the technical solution and the inventive concept of the present invention within the technical scope of the present invention.
Claims (7)
1. The auxiliary agent for the suspending agent is characterized by comprising the following raw materials: 15-65% of amphiphilic oil-based modified bisphenol A epoxy resin, 10-35% of triethanolamine dodecylbenzene sulfonate, 10-40% of phenethyl phenol polyoxyethylene ether and 10-45% of alkyl glycoside.
2. The suspending agent aid as claimed in claim 1, wherein the preparation method of the suspending agent aid comprises the following steps:
and uniformly stirring the amphiphilic oil-based modified bisphenol A epoxy resin, triethanolamine dodecylbenzene sulfonate, phenethylphenol polyoxyethylene ether and alkyl glycoside to obtain the auxiliary agent for the suspending agent.
3. A validamycin and carbendazim compound suspending agent, which is characterized by comprising the auxiliary agent for the suspending agent in any one of claims 1-2.
4. The validamycin and carbendazim compound suspending agent as claimed in claim 3, which is characterized by comprising the following raw materials: 20% of carbendazim, 4% of validamycin, 8% of auxiliary agent for suspending agent, 0.3% of xanthan gum, 0.3% of benzoic acid, 0.5% of defoaming agent and 66.9% of water.
5. The validamycin and carbendazim compound suspending agent as claimed in claim 4, wherein the preparation method of the validamycin and carbendazim compound suspending agent comprises the following steps:
(1) adding the suspending agent and the auxiliary agent into water, and uniformly stirring to obtain an auxiliary agent solution;
(2) adding carbendazim and validamycin into the aid solution, and uniformly stirring to obtain a mixed solution;
(3) adding xanthan gum, benzoic acid and a defoaming agent into the mixed solution in sequence; and after being uniformly stirred, the mixture is sheared at a high speed and then is put into a grinding medium for grinding, and the validamycin and carbendazim compound suspending agent is obtained.
6. The validamycin and carbendazim compound suspending agent as claimed in claim 5, wherein the grinding time in the step (3) is 2-3 hours.
7. The validamycin and carbendazim compound suspending agent as claimed in claim 5, wherein the particle size D90 of the validamycin and carbendazim compound suspending agent is less than 5 microns.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010732832.8A CN111903672A (en) | 2020-07-27 | 2020-07-27 | Auxiliary agent for suspending agent and validamycin and carbendazim compound suspending agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010732832.8A CN111903672A (en) | 2020-07-27 | 2020-07-27 | Auxiliary agent for suspending agent and validamycin and carbendazim compound suspending agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111903672A true CN111903672A (en) | 2020-11-10 |
Family
ID=73280253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010732832.8A Pending CN111903672A (en) | 2020-07-27 | 2020-07-27 | Auxiliary agent for suspending agent and validamycin and carbendazim compound suspending agent |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111903672A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102060618A (en) * | 2010-12-13 | 2011-05-18 | 湖南大方农化有限公司 | Preparation method of water dispersible granule medicinal fertilizer |
| CN102246782A (en) * | 2010-05-21 | 2011-11-23 | 王海林 | Jinggang.carbendazim suspension agent |
| CN103027057A (en) * | 2011-09-29 | 2013-04-10 | 郁志兰 | Composite pesticide suspending agent |
| CN104145953A (en) * | 2014-07-21 | 2014-11-19 | 宁德师范学院 | Suspending agent applied to seed coating and use method of suspending agent |
| CN105145622A (en) * | 2015-09-25 | 2015-12-16 | 山东潍坊润丰化工股份有限公司 | Glyphosate salt and 2,4-D ester weeding composition and mixing method and application thereof |
| CN110105542A (en) * | 2019-05-20 | 2019-08-09 | 南京太化化工有限公司 | A kind of parents' oil base modified bisphenol A type epoxy resin surface activating agent and the preparation method and application thereof |
| CN111109251A (en) * | 2019-12-18 | 2020-05-08 | 中化化工科学技术研究总院有限公司 | Wetting dispersant and pendimethalin suspending agent using same |
-
2020
- 2020-07-27 CN CN202010732832.8A patent/CN111903672A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102246782A (en) * | 2010-05-21 | 2011-11-23 | 王海林 | Jinggang.carbendazim suspension agent |
| CN102060618A (en) * | 2010-12-13 | 2011-05-18 | 湖南大方农化有限公司 | Preparation method of water dispersible granule medicinal fertilizer |
| CN103027057A (en) * | 2011-09-29 | 2013-04-10 | 郁志兰 | Composite pesticide suspending agent |
| CN104145953A (en) * | 2014-07-21 | 2014-11-19 | 宁德师范学院 | Suspending agent applied to seed coating and use method of suspending agent |
| CN105145622A (en) * | 2015-09-25 | 2015-12-16 | 山东潍坊润丰化工股份有限公司 | Glyphosate salt and 2,4-D ester weeding composition and mixing method and application thereof |
| CN110105542A (en) * | 2019-05-20 | 2019-08-09 | 南京太化化工有限公司 | A kind of parents' oil base modified bisphenol A type epoxy resin surface activating agent and the preparation method and application thereof |
| CN111109251A (en) * | 2019-12-18 | 2020-05-08 | 中化化工科学技术研究总院有限公司 | Wetting dispersant and pendimethalin suspending agent using same |
Non-Patent Citations (1)
| Title |
|---|
| 郑艳等: "烷基糖苷发展现状及新进展", 《日用化学品科学》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008261509B2 (en) | Suspension concentrate of Zn thiodiazole and preparation thereof | |
| CN101785455B (en) | Pesticide oil suspension agent and preparation method thereof | |
| CN109479885B (en) | Prothioconazole dispersible oil suspending agent | |
| CN101496513B (en) | Difenoconazole suspending seed-dressing agent and preparation method thereof | |
| CN113545342A (en) | Efficient auxiliary agent suitable for 25% pymetrozine-containing pesticide suspending agent | |
| CN102187862A (en) | Pesticide composition containing pendimethalin and preparation method thereof | |
| CN109699653B (en) | Epoxiconazole aqueous suspension agent and preparation method thereof | |
| CN111903672A (en) | Auxiliary agent for suspending agent and validamycin and carbendazim compound suspending agent | |
| CN104542618A (en) | Synergetic acaricidal composition containing cyenopyrafen and etoxazole | |
| CN107047546A (en) | A kind of dispersible oil-suspending agent of Mancozeb using mineral oil as medium and preparation method thereof | |
| CN109644996B (en) | Suspending agent composition containing validamycin A and hexaconazole | |
| CN112300380A (en) | Alkoxylation block copolymer of agricultural auxiliary agent and preparation method and application thereof | |
| CN106234393A (en) | A kind of agricultural chemicals suspension agent containing hexaconazole and carbendazim and preparation method thereof | |
| CN108782550A (en) | A kind of microcapsule suspension agent producing process | |
| CN101720757A (en) | Kresoxim methyl and epoxiconazole composition suspended emulsion and preparation method thereof | |
| CN110150283B (en) | Spirodiclofen suspending agent and preparation method thereof | |
| CN104255737A (en) | Difenoconazole-propiconazole suspension emulsion and preparation method thereof | |
| CN114176072A (en) | Emamectin benzoate B2 suspending agent and preparation method thereof | |
| JPS60155403A (en) | Aqueous suspending wood protective composition | |
| CN107736347B (en) | clodinafop-propargyl wettable powder and preparation method thereof | |
| CN112205398A (en) | Azocyclotin water suspending agent and preparation method thereof | |
| CN102027989B (en) | High content chlorpyrifos suspending agent and preparation method thereof | |
| CN114208822B (en) | Suspending agent containing prothioconazole and meperflutonazol and preparation method thereof | |
| CN108164515B (en) | Double-target-point agricultural bactericide containing distyryl and preparation method and application thereof | |
| CN115997761B (en) | Compound nano suspending agent and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |